Samsung Biologics U.S. expansion is gaining momentum through a landmark acquisition of Human Genome Sciences from GSK, a move that marks its first biomanufacturing presence in the United States.
In a deal valued at USD 280 million, Samsung Biologics America, a wholly owned subsidiary of...
Abu Dhabi Finance Week 2025 opens today with a clear ambition: to position the Emirate not just as a participant in global finance, but as its architect.
Running from 8–11 December at Al Maryah Island, the event gathers a formidable coalition of global investors, sovereign...
On 17 October 2025, credit rating agency Standard & Poor’s downgraded France’s sovereign rating from "AA-" to "A+", less than a month after Fitch Ratings took a similar step. While not entirely unexpected by seasoned observers, this dual downgrade sends a clear warning signal...
“Moscow calls for peace”, these words, calmly spoken by Andrey Lugovoy in a Telegram video published on 20 October 2025, swiftly unsettled international markets. The message didn’t come from a diplomat but from a man deeply entrenched in Russia’s security state: a former KGB...
The long-term economic partnership between the United States and the Democratic Republic of Congo, formalised at the U.S.–DRC Economic Forum in Washington, marks a strategic turning point in Africa's economic landscape. Far from being a routine investment event, this forum symbolises a mutual commitment...
Behind the diplomatic smiles, a ghost rises. In the background of recent trade discussions between Washington and Ottawa, a term long thought buried has returned to the negotiating table: Keystone XL pipeline. This ‘zombie’ infrastructure project — axed by the Biden administration in a...
